Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment
Life · 28.10.2025 · 15 (11) · 1675
DOI: 10.3390/life15111675 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 28.10.2025. Verfasst von Paschalis Karakasis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital, 54124 Thessaloniki, Greece. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Arrhythmia-induced cardiomyopathy (AIC) represents a potentially reversible form of LV dysfunction in which sustained atrial fibrillation (AF) and irregular, often rapid, ventricular activation drive maladaptive electrical, structural, and metabolic remodeling. Beyond simple rate effects, AIC reflects perturbed calcium handling, oxidative stress, and fibro-inflammatory signaling that propagate atrial–ventricular crosstalk and energetic failure. Clinically, attribution remains challenging because AF may be the cause, consequence, or marker of underlying myocardial disease; however, substantial improvement in LVEF after durable rhythm control is strongly supportive of an AIC component. A disciplined diagnostic pathway—integrating rhythm burden quantification, echocardiographic deformation indices, cardiac magnetic resonance, and natriuretic peptide trajectories—can refine pre-test probability and guide treatment intensity. Early rhythm control has emerged as a disease-modifying strategy in AF with HF, with catheter ablation often central to burden reduction and reverse remodeling; in parallel, rapid initiation of guideline-directed HF therapy and targeted cardiometabolic interventions may favor substrate regression and facilitate durable sinus rhythm. Uncertainties persist regarding standardized AIC case definition, arrhythmia burden thresholds that secure sustained recovery, optimal sequencing of rhythm- and substrate-directed therapies, and criteria for de-escalation of HF treatment after recovery. This review synthesizes contemporary mechanistic, diagnostic, and therapeutic evidence on AIC in AF and delineates priorities for future trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital, 54124 Thessaloniki, Greece.
- First Cardiology Department, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 10679 Athens, Greece.
- Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, Harefield Hospital, London UB9 6JH, UK.
- Department of Pharmacology, University of Athens, 75 Mikras Asias Avenue, 11527 Goudi, Greece.
- Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, 54124 Thessaloniki, Greece.
ORCID-Profile: Paschalis Karakasis, Panagiotis Theofilis, Panayotis K Vlachakis, Anastasios Apostolos, Nikolaos Ktenopoulos, Dimitrios Patoulias, Antonios P Antoniadis, Nikolaos Fragakis
Zitieren
APA
Karakasis, P., Theofilis, P., Vlachakis, P. K., Apostolos, A., Ktenopoulos, N., Grigoriou, K., Patoulias, D., Antoniadis, A. P., & Fragakis, N. (2025). Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment. Life, 15(11), 1675. https://doi.org/10.3390/life15111675
Vancouver
Karakasis P, Theofilis P, Vlachakis PK, Apostolos A, Ktenopoulos N, Grigoriou K, et al. Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment. Life. 2025;15(11):1675. doi:10.3390/life15111675
BibTeX
@article{Karakasis2025,
author = {Karakasis, Paschalis and Theofilis, Panagiotis and Vlachakis, Panayotis K and Apostolos, Anastasios and Ktenopoulos, Nikolaos and Grigoriou, Konstantinos and Patoulias, Dimitrios and Antoniadis, Antonios P and Fragakis, Nikolaos},
title = {Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment},
journal = {Life},
year = {2025},
volume = {15},
number = {11},
pages = {1675},
doi = {10.3390/life15111675}
}
EUVIMED